IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 51 a 100 di 271
Titolo Data di pubblicazione Autore(i) File
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 1-gen-2009 Atzeni, F; Benucci, M; Cimmino, M; Cutolo, M; DE VITA, Salvatore; Fabris, Martina; Masolini, Paola; Morassi, P; Pellerito, R; Quartuccio, Luca; Salvin, Sara; Saracco, M; SARZI PUTTINI, P.
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 1-gen-2009 Salvin, S; Quartuccio, L; Maset, M; Lombardi, S; Sacco, S; Mansutti, E; De Vita, S
Use of teriparatide in osteoporosis due to active rheumatic diseases 1-gen-2009 Salvin, S; Maset, M; Quartuccio, L; Sacco, S; De Marchi, G; De Vita, S
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 1-gen-2010 DE VITA, Salvatore; Quartuccio, Luca; Masolini, P; Stefania, S; De Marchi, G; Zabotti, A.
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 1-gen-2010 Fabris, M; Quartuccio, Luca; Lombardi, S; Saracco, M; Atzeni, F; Carletto, A.
efficacy of methotrexate in polymyalgia rheumatica 1-gen-2010 M., Regis; Quartuccio, Luca; P., Venturini; G. F., Ferraccioli; DE VITA, Salvatore
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 1-gen-2010 Salvin, S; Quartuccio, Luca; Maset, M; Corazza, L; De Marchi, G; Lombardi, S; DE VITA, Salvatore
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 1-gen-2010 DE VITA, Salvatore; Quartuccio, Luca; P., Masolini; S., Stefania; G., De Marchi; A., Zabotti; C., Mazzaro; P. Scaini M., Lenzi; M., Campanini; S., Scarpato; A., Tavoni; M., Pietrogrande; C., Ferri; M. T., Mascia; D., Roccatello; A. L., Zignego; P., Pioltelli; A., Gabrielli; D., Filippini; O., Perrella; S., Migliaresi; M., Galli; G., Monti; S., Bombardieri
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 1-gen-2010 Fabris, M; Quartuccio, Luca; Lombardi, S; Benucci, M; Manfredi, M; Saracco, M; Atzeni, F; Morassi, P; Cimmino, Ma; Pontarini, E; Fabro, C; Pellerito, R; Sarzi Puttini, P; Cutolo, M; Carletto, A; Bambara, Lm; Fischetti, F; Curcio, Francesco; Tonutti, E; DE VITA, Salvatore
the role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism Citation: Ann Rheum Dis 2010;69(Suppl3):671 114)F. Atzeni, A. Batticciotto, M. Benucci, M. Manfredi, L. Quartuccio, S. De Vita, R. Caporali, F. Bobbio-Pallavicini4 R. Pellerito, S. Pennetta, R. Gorla, T. Ziglioli, L. Macchioni, A. Marchesoni, G. De Marco, N. Carrozzo, M. Covelli, P. Sarzi-Puttini Rituximab in patients with rheumatoid arthritis: prospective data from an italian multicenter study 1-gen-2010 M., Fabris; Quartuccio, Luca; S., Lombardi; M., Saracco; F., Atzeni; A., Carletto; M., Cimmino; C., Fabro; E., Pontarini; R., Pellerito; L., Bambara; P., Sarzi Puttini; M., Cutolo; M., Benucci; P., Morassi; F., Fischetti; M., Padovan; M., Manfredi; G., Marcello; Curcio, Francesco; E., Tonutti; DE VITA, Salvatore
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis Ann Rheum Dis 2010;69(Suppl3):704 1-gen-2010 S., Salvin; Quartuccio, Luca; M., Maset; L., Corazza; G., De Marchi; S, Lombardi; DE VITA, Salvatore
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease. 1-gen-2010 S., Salvin; Quartuccio, Luca; T., Moroldo; E., Mansutti; M., Maset; S., Lombardi; DE VITA, Salvatore
Rituximab in patients with rheumatoid arthritis: prospective data from an italian multicenter study 1-gen-2010 Atzeni, F; Batticciotto, A; Benucci, M; Manfredi, M; Quartuccio, Luca; DE VITA, Salvatore
Serum levels of anti-CPP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab 1-gen-2010 Fabris, Martina; DE VITA, Salvatore; Blasone, Nadia; Visentini, Daniela; Pezzarini, Elena; Pontarini, Elena; Fabro, Cinzia; Quartuccio, Luca; Mazzolini, Saulle; Curcio, Francesco; Tonutti, Elio
Preliminary classification criteria for the cryoglobulinemic syndrome 1-gen-2010 DE VITA, Salvatore; Soldano, F; Isola, Miriam; Monti, G; Gabrielli, A; Tzoufas, A; Ferri, C; Ferraccioli, Gf; Quartuccio, Luca
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 1-gen-2010 DE VITA, Salvatore; Quartuccio, Luca
La sindrome di Sjogren 1-gen-2010 DE VITA, Salvatore; Quartuccio, Luca; Fabris, M.
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 1-gen-2010 DE VITA, Salvatore; Quartuccio, Luca; Isola, Miriam; P., Masolini; S., Sacco; G., De Marchi; S., Mazzaro; P., Scaini; M., Lenzi; M., Campanini; S., Scarpato; A., Tavoni; M., Pietrogrande; C., Ferri; Mascia, M. T.; D., Roccatello; Zignego, A. L.; P., Pioltelli; A., Gabrielli; D. Filippini O., Perella; S., Migliaresi; M., Galli; G., Monti; S., Bombardieri
Efficacy of methotrexate in polymyalgia rheumatica 1-gen-2010 Regis, M; Quartuccio, Luca; Venturini, P; Ferraccioli, Gf; DE VITA, Salvatore
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease 1-gen-2010 Salvin, S; Quartuccio, Luca; Moroldo, T; Mansutti, E; Maset, M; Lombardi, S; DE VITA, Salvatore
Efficacy of abatacept in a refractory case of adult-onset Still's disease 1-gen-2010 Quartuccio, Luca; Maset, M; DE VITA, Salvatore
Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia 1-gen-2010 Quartuccio, Luca; Petrarca, A; Mansutti, E; Pieroni, S; Calcabrini, L; Avellini, C; Zignego, Al; DE VITA, Salvatore
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 1-gen-2010 Quartuccio, Luca; DE VITA, Salvatore
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 1-gen-2011 Pietrogrande, M; DE VITA, Salvatore; Zignego, Al; Pioltelli, P; Sansonno, D; Sollima, S; Atzeni, F; Saccardo, F; Quartuccio, Luca; Bruno, S; Bruno, R; Campanini, M; Candela, M; Castelnovo, L; Gabrielli, A; Gaeta, Gb; Marson, P; Mascia, Mt; Mazzaro, C; Mazzotta, F; Meroni, P; Montecucco, C; Ossi, E; Piccinino, F; Prati, D; Puoti, M; Riboldi, P; Riva, A; Roccatello, D; Sagnelli, E; Scaini, P; Scarpato, S; Sinico, R; Taliani, G; Tavoni, A; Bonacci, E; Renoldi, P; Filippini, D; Sarzi Puttini, P; Ferri, C; Monti, G; Galli, M.
Characteristics of primary sjögren's syndrome (pss) patients with cryoglobulinemia in a large cohort of patients, and differences between hypergammaglobulinemic and cryoglobulinemic vasculitis in pss 1-gen-2011 Quartuccio, Luca; Maset, M; Baldini, C; Priori, R; Bartoloni Bocci, E; Carubbi, F; Isola, Miriam; Salvin, S; Luciano, N; Minniti, A; Alunno, A; Gregoraci, G; Giacomelli, R; Gerli, R; Valesini, G; Bombardieri, S; DE VITA, Salvatore
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 1-gen-2011 Quartuccio, Luca; Fabris, M; Maset, M; Pontarini, E; Zabotti, A; DE VITA, Salvatore
Chlamydophila psittaci subclinical infection in chronic polyarthritis 1-gen-2011 Fabris, M.; DE VITA, Salvatore; Pasini, E.; Quartuccio, Luca; Pontarini, E.; Lombardi, S.; Fabro, C.; Sarzi Puttini, P.; Pellerito, R.; Belucci, M.; Morassi, P.; Biasi, D.; Curcio, Francesco; Dolcetti, R.
HCV-related cryoglobulinemic syndrome beginning as isolated gynaecologic vasculitis 1-gen-2011 Quartuccio, Luca; Maset, M; DI LORETO, Carla; DE VITA, Salvatore
Preliminary classification criteria for the cryoglobulinaemic vasculitis 1-gen-2011 DE VITA, Salvatore; Soldano, F; Isola, Miriam; Monti, G; Gabrielli, A; Tzioufas, A; Ferri, C; Ferraccioli, Gf; Quartuccio, Luca; Corazza, L; DE MARCHI, G; Casals, Mr; Voulgarelis, M; Lenzi, M; Saccardo, F; Fraticelli, P; Mascia, Mt; Sansonno, D; Cacoub, P; Tomsic, M; Tavoni, A; Pietrogrande, M; Zignego, Al; Scarpato, S; Mazzaro, C; Pioltelli, P; Steinfeld, S; Lamprecht, P; Bombardieri, S; Galli, M.
Gestione di farmaci biologici ad alto costo in reumatologia e utilizzo di predittori di risposta: il modello dell'anticorpo monoclonale anti-CD20 (Rituximax) nell'artrite reumatoide 13-mag-2011 Quartuccio, Luca
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 1-gen-2012 Fabris, M; Quartuccio, Luca; Lombardi, S; Saracco, M; Atzeni, F; Carletto, A; Cimmino, M; Fabro, C; Pontarini, E; Pellerito, R; Bambara, Lm; SARZI PUTTINI, P; Cutolo, M; Manfredi, M; Benucci, M; Morassi, P; Fischetti, F; Padovan, M; Govoni, M; Curcio, Francesco; Tonutti, E; DE VITA, Salvatore
Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism 1-gen-2012 Quartuccio, Luca; Salvin, S; Fabris, M; Benucci, M; Pellerito, R; Furian, C; Masolini, P; Cimmino, M; Troncon, M. G.; Guarrera, G. M.; DE VITA, Salvatore
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 1-gen-2012 Quartuccio, Luca; Salvin, S.; Zuliani, F.; Mansutti, E.; DE VITA, Salvatore
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 1-gen-2012 R., Priori; A., Gattamelata; M., Modesti; S., Colafrancesco; Maset, Marta; Quartuccio, Luca; DE VITA, Salvatore; E., Bartoloni; A., Alunno; R., Gerli; F., Strigini; C., Baldini; C., Tani; M., Mosca; S., Bombardieri; G., Valesini
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 1-gen-2012 De Vita, S.; Quartuccio, L.; Isola, M; Mazzaro, C.; Scaini, P.; Lenzi, M.; Campanini, M.; Naclerio, C.; Tavoni, A.; Pietrogrande, M.; Ferri, C.; Mascia, M. T; Masolini, P.; Zabotti, A.; Maset, M.; Roccatello, D.; Zignego, A. L.; Pioltelli, P.; Gabrielli, A.; Filippini, D.; Perrella, O.; Migliaresi, S.; Galli, M.; Bombardieri, S.; Monti, G.
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 1-gen-2012 DE VITA, Salvatore; le Seror, R; Quartuccio, Luca; Desmoulins, F; Salvin, S; Baron, G; Fabris, Martina; Ravaud, P; Isola, Miriam; Mariette, X.
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 1-gen-2012 Quartuccio, Luca; F., Tuniz; B., Petralia; B., Zanotti; M., Skrap; DE VITA, Salvatore
Classification of cryoglobulinemic vasculitis 1-gen-2012 DE VITA, Salvatore; Quartuccio, Luca
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 1-gen-2012 R., Priori; A., Gattamelata; M., Modesti; S., Colafrancesco; M., Maset; Quartuccio, Luca
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 1-gen-2012 Quartuccio, Luca; Schiavon, F; Zuliani, F; Carraro, V; Catarsi, E; Tavoni, A; Bombardieri, S; Punzi, L; DE VITA, Salvatore
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. 1-gen-2012 Quartuccio, Luca; Isola, Miriam; Corazza, L; Maset, M; Monti, G; Gabrielli, A; Tzioufas, Ag; Ferri, C; Ferraccioli, G; Ramos Casals, M; Voulgarelis, M; Lenzi, M; Mascia, Mt; Sansonno, D; Cacoub, P; Tomsic, M; Tavoni, A; Pietrogrande, M; Zignego, Al; Scarpato, S; Pioltelli, P; Steinfeld, S; Lamprecht, P; Galli, M; Bombardieri, S; DE VITA, Salvatore
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 1-gen-2012 Quartuccio, L; Maset, M; De Maglio, G; Pontarini, E; Fabris, M; Mansutti, E.; Mariuzzi, L; Pizzolitto, S; Beltrami, Ca; De Vita, S
Common Features in Lymphoproliferative Complications in the Course of Primary Sjo¨gren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients 1-gen-2012 Quartuccio, L; Baldini, C; Priori, R; Bocci Bartoloni, E; Carubbi, F; Isola, M; Maset, M; Salvin, S; Luciano, N
Lymphoproliferative complications in the course of primary sjögren's syndrome: prevalence and common features in a large cohort of patients 1-gen-2012 Quartuccio, Luca; Baldini, C; Priori, R; Bartoloni Bocci, E; Carubbi, F; Isola, Miriam; Maset, M; Salvin, S; Luciano, N; Picarelli, G; Alunno, A; Marrelli, A; Gerli, R; Valesini, G; Bombardieri, S; DE VITA, Salvatore
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 1-gen-2012 DE VITA, Salvatore; Quartuccio, Luca; S., Salvin; L., Corazza; A., Zabotti; M., Fabris
Myositis in primary sjögren's syndrome: data from a multicenter cohort 1-gen-2012 S., Colafrancesco; A., Gattamelata; M., Modesti; A., Minniti; G., D'Amati; C., Giordano; Maset, Marta; Quartuccio, Luca; E., Bartoloni; F., Carrubi; F., Cipriani; C., Baldini; N., Luciano; DE VITA, Salvatore; R., Gerli; R., Giacomelli; S., Bombardieri; G., Valesini; R., Priori
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 1-gen-2013 Mariette, X; Seror, R; Quartuccio, Luca; Baron, G; Salvin, S; Fabris, M; Desmoulins, F; Nocturne, G; Ravaud, P; DE VITA, Salvatore
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. 1-gen-2013 Fabris, M; Quartuccio, Luca; Vital, E; Pontarini, E; Salvin, S; Fabro, C; Zabotti, A; Benucci, M; Manfredi, M; Ravagnani, V; Biasi, D; Atzeni, F; Sarzi Puttini, P; Morassi, P; Fischetti, F; Bazzicchi, L; Saracco, M; Pellerito, R; Cimmino, M; Carraro, V; Semeraro, A; Schiavon, F; Caporali, R; Bortolotti, R; Govoni, M; Fogolari, Federico; Tonutti, E; Bombardieri, S; Emery, P; DE VITA, Salvatore
Health-related quality of life in severe cryoglobulinaemic vasculitis and improvement after B-cell depleting therapy. 1-gen-2013 Quartuccio, Luca; Isola, Miriam; Masolini, P; Scaini, P; Zani, R; Tavoni, A; Pietrogrande, M; Bombardieri, S; DE VITA, Salvatore
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 1-gen-2013 Cojutti, P. G.; Franceschi, L.; Tursi, V.; Livi, Ugolino; Zabotti, A.; Sacco, S.; Quartuccio, Luca; DE VITA, Salvatore; Baraldo, Massimo
Mostrati risultati da 51 a 100 di 271
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile